168 related articles for article (PubMed ID: 1996575)
41. ASO titre and serum complement (C3) in post-streptococcal glomerulonephritis.
Shroff KJ; Ravichandran R; Acharya VN
J Postgrad Med; 1984 Jan; 30(1):27-32. PubMed ID: 6716306
[No Abstract] [Full Text] [Related]
42. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
[TBL] [Abstract][Full Text] [Related]
43. Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response.
Yoshizawa N; Yamakami K; Fujino M; Oda T; Tamura K; Matsumoto K; Sugisaki T; Boyle MD
J Am Soc Nephrol; 2004 Jul; 15(7):1785-93. PubMed ID: 15213266
[TBL] [Abstract][Full Text] [Related]
44. Prolonged hypocomplementemia in poststreptococcal acute glomerulonephritis.
Dedeoglu IO; Springate JE; Waz WR; Stapleton FB; Feld LG
Clin Nephrol; 1996 Nov; 46(5):302-5. PubMed ID: 8953118
[TBL] [Abstract][Full Text] [Related]
45. Relative inefficiency of terminal complement activation.
Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
[TBL] [Abstract][Full Text] [Related]
46. Elevated urinary plasmin activity resistant to alpha2-antiplasmin in acute poststreptococcal glomerulonephritis.
Oda T; Tamura K; Yoshizawa N; Sugisaki T; Matsumoto K; Hattori M; Sawai T; Namikoshi T; Yamada M; Kikuchi Y; Suzuki S; Miura S
Nephrol Dial Transplant; 2008 Jul; 23(7):2254-9. PubMed ID: 18223261
[TBL] [Abstract][Full Text] [Related]
47. The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy.
Cybulsky AV; Quigg RJ; Salant DJ
J Immunol; 1986 Sep; 137(5):1511-6. PubMed ID: 3745914
[TBL] [Abstract][Full Text] [Related]
48. Sensitive ELISA for quantitating the terminal membrane C5b-9 and fluid-phase SC5b-9 complex of human complement.
Hugo F; Krämer S; Bhakdi S
J Immunol Methods; 1987 May; 99(2):243-51. PubMed ID: 3584995
[TBL] [Abstract][Full Text] [Related]
49. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
Garred P; Michaelsen TE; Aase A; Mollnes TE
J Immunol; 1990 Jan; 144(1):198-203. PubMed ID: 2295791
[TBL] [Abstract][Full Text] [Related]
50. Urinary excretion of terminal complement complexes in glomerular disease.
Kusunoki Y; Akutsu Y; Itami N; Tochimaru H; Nagata Y; Takekoshi Y; Sagawa A; Kataoka Y; Nagasawa S
Nephron; 1991; 59(1):27-32. PubMed ID: 1944744
[TBL] [Abstract][Full Text] [Related]
51. [Poststreptococcal glomerulonephritis].
García-Fuentes M; Arias M
An Esp Pediatr; 1981 Aug; 15(2):166-81. PubMed ID: 7034610
[TBL] [Abstract][Full Text] [Related]
52. Prognosis of acute poststreptococcal glomerulonephritis (APSGN) is excellent in children, when adequately diagnosed.
Kasahara T; Hayakawa H; Okubo S; Okugawa T; Kabuki N; Tomizawa S; Uchiyama M
Pediatr Int; 2001 Aug; 43(4):364-7. PubMed ID: 11472580
[TBL] [Abstract][Full Text] [Related]
53. The potential role for nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis.
Yamakami K; Yoshizawa N; Wakabayashi K; Takeuchi A; Tadakuma T; Boyle MD
Methods; 2000 Jun; 21(2):185-97. PubMed ID: 10816380
[TBL] [Abstract][Full Text] [Related]
54. Infection-related glomerulonephritis: understanding mechanisms.
Nadasdy T; Hebert LA
Semin Nephrol; 2011 Jul; 31(4):369-75. PubMed ID: 21839370
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis.
Cu GA; Mezzano S; Bannan JD; Zabriskie JB
Kidney Int; 1998 Sep; 54(3):819-26. PubMed ID: 9734606
[TBL] [Abstract][Full Text] [Related]
56. [Recurrent post-infectious immune complex glomerulonephritis with persistent activation of the alternative complement pathway].
Arslan-Kirchner M; Ehrich JH; Kirschfink M; Helmchen U; Brodehl J
Monatsschr Kinderheilkd; 1990 Feb; 138(2):81-4. PubMed ID: 2138710
[TBL] [Abstract][Full Text] [Related]
57. Streptococcal antibodies and complement components in tropical post-streptococcal glomerulonephritis.
Koshi G; Sridharan G; Thangavelu CP; Shastry JC
Trans R Soc Trop Med Hyg; 1983; 77(2):189-91. PubMed ID: 6868098
[TBL] [Abstract][Full Text] [Related]
58. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
[TBL] [Abstract][Full Text] [Related]
59. C3 metabolism in acute glomerulonephritis: implications for sites of complement activation.
Endre ZH; Pussell BA; Charlesworth JA; Coovadia HM; Seedat YK
Kidney Int; 1984 Jun; 25(6):937-41. PubMed ID: 6236326
[TBL] [Abstract][Full Text] [Related]
60. Measles and acute glomerulonephritis.
Lin CY; Hsu HC
Pediatrics; 1983 Mar; 71(3):398-401. PubMed ID: 6219335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
